Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Early Ankylosing Spondylitis
NCT00936143Phase 4Completed
- Start
- Jan 2008
- Primary completion
- Sep 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in ankylosing spondylitis (AS). Started Jan 2008; status: completed.
02
Drugs
infliximab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00936143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936143.